Is Supriya Lifescience stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Supriya Lifescience pays dividends. Last time was Sunday 27th of October 2024 where the investors holding the stock on Friday 20th of September 2024 were paid INR0.8 per share. Over the last 3 times between 2022 and 2024, Supriya Lifescience has paid INR2 with an average of INR0.67 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Supriya Lifescience 10 years ago, but if you had invested on Tuesday 28th of December 2021 when the price was INR390.85, you would have made a profit of INR204.20 per share or 52.25%
Yes, the average daily trading liquidity for Supriya Lifescience is INR552 006 thousand. You should therefore be able to get in and out of your positions relatively fast.
Supriya Lifescience has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 5.43, the company's ability to pay off the debt is good. Supriya Lifescience has a very good net profit margin of 20.88% and should have very high tolerances against inflation.
We have calculated the inflation risk for Supriya Lifescience to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.